Surgery versus stereotactic body radiation therapy for early-stage lung cancer: Who's down for the count?

Journal of Clinical Oncology

Volumn 28, Issue 6, 2010, Pages 907-909

  Timmerman, Robert D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMICAL VARIATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; DISEASE SEVERITY; EDITORIAL; HUMAN; LOBECTOMY; LUNG CANCER; LUNG RESECTION; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; STEREOTACTIC BODY RADIATION THERAPY; WEDGE RESECTION; CANCER STAGING; LUNG TUMOR; PATHOLOGY; RADIOSURGERY;

HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY;

EID: 77949892388     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.5165     Document Type: Editorial

References (17)

1. Timmerman R, Abdulrahman R, Kavanagh BD, et al: Lung cancer: A model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol 40:368-385, 2007
2. Dosoretz DE, Katin MJ, Blitzer PH, et al: Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 6:98-104, 1996 (Pubitemid 26119516)
3. McGarry RC, Song G, des Rosiers P, et al: Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 121:1155-1158, 2002 (Pubitemid 34280436)
4. Baumann P, Nyman J, Hoyer M, et al: Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290-3296, 2009
5. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70:685-692, 2008
6. Timmerman R, Paulus R, Galvin J, et al: RTOG 0236: Stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients: American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting, Chicago, IL. Int J Radiat Oncol Biol Phys 75:S3, 2009 (suppl)
7. Onishi H, Araki T, Shirato H, et al: Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101:1623-1631, 2004 (Pubitemid 39318910)
8. Onishi H, Shirato H, Nagata Y, et al: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-S100, 2007 (Pubitemid 47183602)
9. Hiraoka M, Ishikura S: A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2:S115-S117, 2007 (Pubitemid 47183605)
10. Timmerman R, Galvin J, Pass H, et al: RTOG 0618: A Phase II Trial of Stereotactic Body Radiation Therapy in the Treatment of Patients With Operable Stage I/II Non-Small Cell Lung Cancer. Philadelphia, PA, Radiation Therapy Oncology Group, 2007, p 67
11. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al: Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 4:1, 2009
12. Dawood O: M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife Radiosurgery for Operable Lung Cancer Patients. http://www.accuray. com/PressReleases.aspx?release=676
13. Grills IS, Mangona VS, Welsh R, et al: Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 28:928-935, 2010
14. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622, 1995; discussion 622-623
15. Reed CE, Harpole DH, Posther KE, et al: Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943-1951, 2003
16. Cerfolio RJ, Bryant AS: Survival of patients with true pathologic stage I non-small cell lung cancer. Ann Thorac Surg 88:917-922, 2009; discussion 922-923
17. Lee Y, Auh SL, Wang Y, et al: Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment. Blood 114:589-595, 2009